Growth Metrics

Utah Medical Products (UTMD) Receivables - Net (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Receivables - Net data on record, last reported at $3.7 million in Q3 2025.

  • For Q3 2025, Receivables - Net changed 0.13% year-over-year to $3.7 million; the TTM value through Sep 2025 reached $3.7 million, changed 0.13%, while the annual FY2024 figure was $4.1 million, 20.73% up from the prior year.
  • Receivables - Net reached $3.7 million in Q3 2025 per UTMD's latest filing, up from $3.6 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $6.0 million in Q3 2022 and bottomed at $3.4 million in Q4 2023.
  • Average Receivables - Net over 5 years is $4.3 million, with a median of $3.9 million recorded in 2025.
  • Peak YoY movement for Receivables - Net: soared 37.6% in 2022, then crashed 42.21% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $5.1 million in 2021, then grew by 11.46% to $5.7 million in 2022, then crashed by 40.72% to $3.4 million in 2023, then rose by 20.73% to $4.1 million in 2024, then fell by 9.01% to $3.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $3.7 million in Q3 2025, $3.6 million in Q2 2025, and $3.9 million in Q1 2025.